News
Great Ormond Street Hospital and Leucid Bio collaborate
Leucid Bio – a company concentrating on a differentiated approach to developing next generation Chimeric Antigen Receptor T-cell (CAR-T) therapies – has announced a commercial manufacturing master services partnership with Great Ormond Street Hospital NHS Foundation Trust (GOSH).